Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic Regimen
Clinical trial NCT02475382 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT02475382
- Sponsor
- Bristol-Myers Squibb
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.